Effect of Gemcitabine and nab-Paclitaxel With or Without Hydroxychloroquine on Patients With Advanced Pancreatic CancerThomas B. Karasic, Peter J. O’Dwyer, Mark H. O’Hara et al.|JAMA Oncology|2019Cited by 289
Phase II Study of Maintenance Rucaparib in Patients With Platinum-Sensitive Advanced Pancreatic Cancer and a Pathogenic Germline or Somatic Variant in <i>BRCA1</i>, <i>BRCA2</i>, or <i>PALB2</i>Kim A. Reiss, Susan M. Domchek, Rosemarie Mick et al.|Journal of Clinical Oncology|2021Cited by 238
Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutationMax M. Wattenberg, Kim A. Reiss, Daniella Asch et al.|British Journal of Cancer|2019Cited by 206
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trialKim A. Reiss, Yara Abdou, Melissa Christiano et al.|Nature Medicine|2025Cited by 189
Evaluation of Cyclophosphamide/GVAX Pancreas Followed by Listeria-Mesothelin (CRS-207) with or without Nivolumab in Patients with Pancreatic CancerTakahiro Tsujikawa, Dung T. Le, Todd S. Crocenzi et al.|Clinical Cancer Research|2020Cited by 151